AUDDIA INC. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by AUDDIA INC. on August 20, 2024, with the earliest event reported on the same date. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Boulder, Colorado. Its common stock (AUUD) and warrants (AUUDW) are registered on the Nasdaq Stock Market.
Key Financial Metrics and Capital Structure
The filing reports a specific capital raise event rather than periodic operating results. Key metrics disclosed include:
- Proceeds: Approximately $2.0 million received from the sale of common stock.
- Shares Issued: 1,650,000 common shares issued to White Lion Capital, LLC.
- Outstanding Shares: Total common stock outstanding increased to 4,444,196 shares as of August 22, 2024.
- Revenue, Profit, and Cash Flow: The filing text does not provide a clear value for revenue, net income, operating cash flow, or margins for the reporting period.
- Debt and Liquidity: The filing text does not provide a clear value for total debt or specific liquidity ratios, though the transaction increased cash proceeds.
Material Changes
The primary material change is the execution of a transaction under the Common Stock Purchase Agreement (the "White Lion Purchase Agreement") entered into on November 14, 2022. On August 20, 2024, the Company closed the sale of 1,650,000 shares to White Lion Capital, LLC. This transaction resulted in a dilution of existing shareholders, increasing the total share count from the prior level to 4,444,196 shares.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure that the information in Items 2.02 and 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act. The transaction was executed pursuant to a pre-existing agreement, indicating a structured approach to capital raising.
Investor Verification Checklist
- Verify the exact closing price per share implied by the $2.0 million proceeds and 1,650,000 shares issued.
- Confirm the current cash balance and burn rate to assess the runway provided by the $2.0 million infusion.
- Review the full terms of the White Lion Purchase Agreement for any remaining purchase obligations or pricing mechanisms.
- Check for any subsequent filings regarding the use of proceeds or changes in the capital structure.